Tumor-Associated Macrophages in Breast Cancer

被引:0
|
作者
Russell D. Leek
Adrian L. Harris
机构
[1] University of Oxford,Cancer Research UK, Molecular Oncology Laboratories
[2] Weatherall Institute of Molecular Medicine,undefined
[3] John Radcliffe Hospital,undefined
[4] Headington,undefined
来源
Journal of Mammary Gland Biology and Neoplasia | 2002年 / 7卷
关键词
breast; tumor; macrophage; angiogenesis; metastasis; hypoxia;
D O I
暂无
中图分类号
学科分类号
摘要
Neoplastic cells form only one part of a complex network of cell types that make up a breast tumor. The normal cell types that make up the nonneoplastic components of tumors include fibroblasts, endothelium, and inflammatory cells, such as tumor associated macrophages (TAMs). TAMs have the potential to carry out both anti- and protumor activities. In their antitumor role TAMs can present tumor antigens to cytotoxic T-cells and are capable of being directly cytotoxic to neoplastic cells. Conversely, TAMs are also able to promote tumor growth directly by secreting breast tumor mitogens, such as epidermal growth factor, and indirectly by stimulating tumor angiogenesis and metastasis. Recent studies have indicated that in breast cancers the protumor role of TAMs is dominant, and that TAMs may be executing a “wound healing” type of process in response to stimuli found in the tumor microenvironment, such as hypoxia. As such, TAMs may provide opportunities for future therapeutic interventions.
引用
收藏
页码:177 / 189
页数:12
相关论文
共 50 条
  • [41] Tumor-associated macrophages: an accomplice in solid tumor progression
    Yibing Chen
    Yucen Song
    Wei Du
    Longlong Gong
    Haocai Chang
    Zhengzhi Zou
    Journal of Biomedical Science, 26
  • [42] Identification of tumor-associated macrophage subsets that are associated with breast cancer prognosis
    Strack, Elisabeth
    Rolfe, P. Alexander
    Fink, Annika F.
    Bankov, Katrin
    Schmid, Tobias
    Solbach, Christine
    Savai, Rajkumar
    Sha, Weixiao
    Pradel, Leon
    Hartmann, Sylvia
    Bruene, Bernhard
    Weigert, Andreas
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (08):
  • [43] Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
    Kumari, Nisha
    Choi, Seung Hong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [44] Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer
    Li, Mei-Ye
    Ye, Wei
    Luo, Ke-Wang
    PHARMACEUTICS, 2024, 16 (07)
  • [45] Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
    Fujimura, Taku
    Kambayashi, Yumi
    Fujisawa, Yasuhiro
    Hidaka, Takanori
    Aiba, Setsuya
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [46] Tumor-Associated Macrophages: A Potential Target for Cancer Therapy
    Tan, Yifan
    Wang, Min
    Zhang, Yang
    Ge, Shengyang
    Zhong, Fan
    Xia, Guowei
    Sun, Chuanyu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Perivascular tumor-associated macrophages and their role in cancer progression
    Bahri, Meriem
    Anstee, Joanne E.
    Opzoomer, James W.
    Arnold, James N.
    ESSAYS IN BIOCHEMISTRY, 2023, 67 (06) : 919 - 928
  • [48] The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
    Fu, Luo-Qin
    Du, Wen-Lin
    Cai, Mao-Hua
    Yao, Jia-Yu
    Zhao, Yuan-Yuan
    Mou, Xiao-Zhou
    CELLULAR IMMUNOLOGY, 2020, 353
  • [49] The promising role of tumor-associated macrophages in the treatment of cancer
    Wang, Hongbin
    Wang, Xueying
    Zhang, Xin
    Xu, Wanhai
    DRUG RESISTANCE UPDATES, 2024, 73
  • [50] Tumor-Associated Macrophages: Combination of Therapies, the Approach to Improve Cancer Treatment
    Moeini, Pedram
    Niedzwiedzka-Rystwej, Paulina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)